Alpha-9 Oncology
BC - VancouverPharmaceutical
Focus: Alpha-9 Oncology is a radiopharmaceutical specialist focused on targeted cancer and neurology treatments, headquartered in Vancouver. The company operates at early clinical stage with a single Phase 1 program.
Profile data last refreshed 16h ago · AI intelligence enriched 2w ago
Open Jobs
2-2 this month
Stable — net -2 jobs in 30d
0 added, 2 removed. Backfill posture.
Should You Work at Alpha-9 Oncology?
AI assessmentBest suited for early-stage-focused professionals seeking deep technical involvement in radiopharmaceutical science with elevated execution risk.
Why Work Here
- Opportunity to work in radiopharmaceuticals, an emerging and specialized modality with high unmet need in oncology
- Early-stage company offers direct impact on drug development and potential equity upside as pipeline advances
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
actinium-225 A9-3408
Metastatic Melanoma[225Ac]Ac-A9-3408
Melanoma MetastaticClinical Trials (1)
Help build intelligence for Alpha-9 Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.